Yu-Feng Huang

Dr. Yu-Feng Huang

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2017 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
PLPing‐Hui Lee
Ping‐Hui Lee
PCPei‐Ming Chu
Pei‐Ming Chu
Pei-Ling HsiehPei-Ling Hsieh
Pei-Ling Hsieh
HYHui‐Wen Yang
Hui‐Wen Yang
Pin Ju ChuehPin Ju Chueh
Pin Ju Chueh
Cheng-Chia YuCheng-Chia Yu
Cheng-Chia Yu

1 October 2011 in Photomedicine and Laser Surgery
Verified
Journal Article
Closed access
HYHui-Wen Yang
Hui-Wen Yang
YHYu-Feng Huang
Yu-Feng Huang
Objective: The purpose of this study was to test the therapeutic efficacy of low- level energy diode laser on persistent idiopathic facial pain (PIFP). Background data: PIFP has presented a diagnosis and management challenge to clinicians. Many patients were misdiagnosed, which resulted in unnecessary dental procedures. Low-level energy diode laser therapy has been applied to different chronic and acute pain disorders, including neck, back, and myofacial pain; degenerative osteoarthritis; and headache, and it may be an effective alternative treatment for PIFP. Methods: A total of 16 patients, who were diagnosed with PIFP, were treated with an 800-nm wavelength diode laser. A straight handpiece having an end size of 0.8 cm in diameter, or an angled handpiece with an end size of 0.5 cm in diameter was used. When laser was applied, the handpiece directly contacted the involved symptomatic region with an energy density of 105 J/cm 2 . Overall pain and discomfort was analyzed with a 10-cm visual analogue scale (VAS) before and after treatment. Results: All patients received diode laser therapy between 1 and10 times. The average pain score was 7.4 before the treatment (ranging from 2.9 to 9.8), and 4.1 after the treatment. An average pain reduction of 43.87% (ranging from 9.3% to 91.8%) was achieved. The pain remained unchanged at a lower level for up to 12 months. Conclusions: Low-level energy diode laser may be an effective treatment for PIFP.

28 August 2021 in Journal of Dental Sciences
Verified
Journal Article
Open access
CWChen-Tsung Weng
Chen-Tsung Weng
SHShir-Ly Huang
Shir-Ly Huang
HYHui-Wen Yang
Hui-Wen Yang
CKChih-Chin Kao
Chih-Chin Kao
CWCheng-Chung Wei
Cheng-Chung Wei
YHYu-Feng Huang
Yu-Feng Huang
The estimated prevalence of xerostomia (lack of saliva) ranges from 10% to 50% of the general population. The oral cavity provides a multivariant environmental habitat to over 700 species of bacteria and fungi. We hypothesized that xerostomia will alter the composition of oral microbiota. Nineteen xerostomia patients and 10 healthy normal volunteers were studied for the oral microbiota. Gingival plaques were collected and microbiota were detected using bacterial 16S ribosomal RNA and analyzed based on the levels of phylum and class. In all cases, phyla of Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, and Proteobacteria make up to 100% of oral microbiota at phylum level. Analyzing individual phylum, presence of Bacteroidetes in xerostomia patients and normal subjects were 23.12 ± 2.56% and 23.23 ± 2.58%, respectively. Mean percentage presence of Firmicutes phylum in xerostomia patients and normal subjects were 18.94 ± 1.83% and 14.06 ± 0.98%, respectively. Statistically significant difference was not observed between xerostomia patients and normal subjects in this study. These observations revealed obvious but not statistically significant changes in oral major microorganism phylum between xerostomia patients and normal subjects in this study. More samples are needed to verify the current results and to use oral microbiota as a tool in the diagnosis of xerostomia.

31 July 2008 in Bone
Verified
Journal Article
Closed access
TCTaranpreet K. Chandhoke
Taranpreet K. Chandhoke
YHYu-Feng Huang
Yu-Feng Huang
FLFei Liu
Fei Liu
GGGloria A. Gronowicz
Gloria A. Gronowicz
DADouglas J. Adams
Douglas J. Adams
BKBarbara E. Kream
Barbara E. Kream

25 December 2021 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
KMKevin Sheng-Kai Ma
Kevin Sheng-Kai Ma
ETEshwar Thota
Eshwar Thota
JHJing‐Yang Huang
Jing‐Yang Huang
YHYu-Feng Huang
Yu-Feng Huang
CHENGCHUNG WEICHENGCHUNG WEI
CHENGCHUNG WEI

24 June 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
CYChengChieh Yang
ChengChieh Yang
YSYee Fun Su
Yee Fun Su
HCHan-Chieh Cheng
Han-Chieh Cheng
YJYi-Chen Juan
Yi-Chen Juan
YCYu-Wei Chiu
Yu-Wei Chiu
CLChung Ji Liu
Chung Ji Liu
Background: Visual oral examination (VOE) is a conventional oral cancer screening method. This study aimed to evaluate the value of methylation marker to assist VOE in identifying oral epithelial dysplasia and oral squamous cell carcinoma (OED/OSCC) from non-cancerous lesions in a real-world situation. Methods: 201 patients with high-risk personal habits who self-perceived oral anomaly were VOE examined, ZNF582 methylation (ZNF582m) tested, and histologically diagnosed. Results: Among them, 132 patients (65.7%) were histologically diagnosed OED/OSCC. Using VOE, 56.1% OED/OSCC patients had possible oral cancer, whereas 37.7% non-OED/OSCC patients had leukoplakia. ZNF582m-positive was detected in 90.2% OED/OSCC patients and 44.9% non-OED/OSCC patients. Various logistic regression models were postulated to evaluate the diagnostic performance of conventional VOE and new strategies using ZNF582m. ROC analysis and its corresponding C-index demonstrated that either triage or co-testing models of VOE and ZNF582m could improve diagnostic performance and discriminative abilities compared with the VOE only approach. Conclusions: In conclusion, methylation marker test shows equivalent performance to an experienced judgment by oral maxillofacial surgeons and plays a significantly supplementary role in increasing the efficacy in identifying oral malignant lesions. ZNF582m may be an especially important tool for family physicians or general dentists to properly diagnose suspicious oral lesions.